Company overview
Basic information
Company name
Biotechpharma, UAB
Company code
300041719
VAT code
LT100001266014
Registered address
Vilnius, Mokslininkų g. 4, LT-08412
Registration date
2004-07-16
Company age: 22 y. 2 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.northwaybiotech.com
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Other research and experimental development on natural sciences and engineering
Ownership form
Privately owned with foreign capital
UAB Biotechnologinės farmacijos centras "Biotechpharma"
Company code: 300041719
Address: Vilnius, Mokslininkų g. 4, LT-08412
VAT code: LT100001266014
Download a detailed company report
Make confident decisions with all the information about Biotechpharma, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Biotechpharma, UAB (company code 300041719) is a private limited liability company registered in 2004 and currently operational. It is classified as a private, large national private non-financial company, operating under a CEO with a board/council. The company is privately owned, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and with capital from foreign investors. Its registered address is Mokslininku g. 4, Vilnius, Vilniaus m. sav., Vilniaus apskr.
The company’s activity is coded N.72.10.90, Research and experimental development on other natural sciences and engineering. In financial year 2024, Biotechpharma generated revenue of €74.04M and net profit of €45.58M, with a net profit margin of 61.6%. This followed revenue of €93.05M and net profit of €50.78M in 2023. Equity stood at €114.94M in 2024, with total assets of €186.56M and liabilities of €61.27M.
Staffing has been lower in recent years: the company averaged 107 employees so far in 2026. The average monthly wage was €4,174.17 so far in 2026, up from €3,984.55 in 2025 and €3,852.75 in 2024.
The company’s activity is coded N.72.10.90, Research and experimental development on other natural sciences and engineering. In financial year 2024, Biotechpharma generated revenue of €74.04M and net profit of €45.58M, with a net profit margin of 61.6%. This followed revenue of €93.05M and net profit of €50.78M in 2023. Equity stood at €114.94M in 2024, with total assets of €186.56M and liabilities of €61.27M.
Staffing has been lower in recent years: the company averaged 107 employees so far in 2026. The average monthly wage was €4,174.17 so far in 2026, up from €3,984.55 in 2025 and €3,852.75 in 2024.